← Back to Patent Explorer
US3622632A Expired / Lapsed US ⏱️ 0.0 years remaining

NOVEL 2-ARYL-1,3-INDANDIONES AND 2-ARYL-2,3-DIHYDROBENZ {8 f{9 {0 INDENE-1,3-DIONES

Assignee: Pfizer Inc
•
Filing: 1968-08-29
•
Granted: 1971-11-23
•
Expires: 1988-08-29
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel 2-aryl-1,3-indandiones and 2-aryl-2,3-dihydrobenz (f) indene-1,3-diones and their use in lowering the blood lipid level in mammals.

Inventors

  • 👤 Joseph G Lombardino
  • 👤 Gerald F Holland

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 17:39
CPC Classifications
C; C07; C07C; C07C309/00; C07C205/00; C07C205/45; C07C317/00; C07C49/00; C07C49/587; C07C49/657; C07C49/665; C07C49/675; C07C49/687; C07C49/697; C07C49/703; C07C49/747; C07C49/753; C07C49/755; C07C2603/00; C07C2603/02; C07C2603/04; C07C2603/06; C07C2603/10; C07C2603/12; C07C2603/16

Claims Analysis

Total Claims: 3
Claim 1
Independent Claim 1 words
2-(2''-naphthyl)-5-bromo-1,3-indandione.
Claim 2
Dependent Claim 1 words
2-(3''-methylphenyl)-5-trifluoromethyl-1,3-indandione.
Claim 3
Dependent Claim 1 words
2-(2''-naphthyl)-5-trifluoromethyl-1,3-indandione.

References Cited (Backward Citations)

GB761816A Cited
US2938925A Cited
US3090813A Cited
US3413353A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1974-11-22 1975-05-24 1975-11-23 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1978-11-22 1979-05-24 1979-11-23 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1982-11-22 1983-05-24 1983-11-23 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag